Twist Bioscience, founded in 2013, is a biotechnology company dedicated to advancing synthetic DNA technology. Its core mission is to drive biological innovations that make the world safer, healthier, and more sustainable. The company offers a range of DNA-based tools and services, including gene synthesis, DNA libraries, and data storage solutions. Twist Bioscience focuses on various markets such as drug discovery, cancer research, human genetics, agricultural biotechnology, animal health, and infectious disease research.
Notable figures associated with Twist Bioscience include co-founder and CEO Emily Leproust. The company has attracted significant investment from prominent venture capital firms and has achieved key milestones such as developing high-throughput DNA synthesis platforms. Twist Bioscience's impact is evident in its contributions to groundbreaking scientific research and its role in enabling advancements across multiple disciplines.
